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Glucocorticoids (GCs) are steroid hormones secreted as the end-product of the
neuroendocrine stress cascade. Both absence and elevated GC mediate neurotoxic
responses, suggesting that a narrow window ranging from physiological to slightly high
GC mediate protective responses. The beneficial effects of GC are attributed to the
transactivation of regulatory proteins and inhibition mediated by glucocorticoid receptor
(GR) interactions with other co-factors. The glucocorticoid induced leucine zipper (GILZ)
is a gene strongly upregulated by GC and mediates many of the anti-inflammatory
and anti-proliferative effects of GC. Although GILZ is constitutively expressed in many
tissues including the brain, the expression has been shown to occur with varying
dynamics suggesting that the local milieu modulates its expression with consequent
effects on cellular responses. Here we investigated the expression profile of GILZ in
lipopolysaccharide (LPS) mediated neuroinflammation model of Alzheimer’s disease (AD).
Our data suggest that the GILZ expression is downregulated in neuroinflammation
correlating inversely with the pro-inflammatory cytokines and innate immune responses.
Keywords: neuroinflammation, glucocorticoid induced leucine zipper, Alzheimer’s disease, toll like receptor-4,
cytokines
INTRODUCTION
Increased plasma glucocorticoids (GCs) are features of both aging and Alzheimer’s disease
(AD; Huang et al., 2009). Endogenous GC released by the adrenal glands play a key role in the
homeostasis by regulating energy metabolism, coordinating immune responses and orchestrating
the adaptive responses to stress. Increased secretion of GC can occur in response to various stimuli
such as low plasma levels of GC, psychological or physical stress. The elevated GC in general is
suppressed by a negative feedback loop, mainly regulated by the hypothalamic pituitary adrenal
axis (HPA; Abrahám et al., 2006; Vyas et al., 2016). However, aging has been associated with a
decreased sensitivity of the HPA axis to GC feedback, which in turn leads to prolonged elevated
levels of plasma GC (Lupien et al., 1999).
Although the profound anti-inflammatory effects of GC suggest a neuroprotective role,
emerging evidence strongly implicate elevated GC in potentiating the pro-inflammatory
responses and neuroinflammation in the central nervous system (CNS). Multiple mechanisms
are suggested for the effects of high GC on brain including dysregulated HPA axis,
alterations in glial functions as well as structural remodeling of neurons with synaptic loss
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(Duque Ede and Munhoz, 2016; Vyas et al., 2016). Classically,
GC act by binding the glucocorticoid receptor (GR) or
the mineralocorticoid receptor (MR) in the cytoplasm. The
ligand bound GR complex translocate to the nucleus and
mediate cellular responses by genomic mechanisms via specific
glucocorticoid response elements (GREs) in the DNA or by
non-genomic protein: protein interactions. The therapeutic
efficacy of GC are attributed to the combined effects of
transactivation of regulatory proteins and inhibition of the
pro-inflammatory transcription factor, the nuclear factor-
kappa B (NF-κB) by tethering (Newton, 2000; Srinivasan and
Lahiri, 2017).
Glucocorticoid induced leucine zipper (GILZ) is a member of
the TSC22 family of proteins that share the TSC box and the
leucine zipper domains. It was originally identified as a gene
rapidly induced by dexamethasone in lymphocytes (D’Adamio
et al., 1997). More recently, its constitutive expression is reported
in multiple cell types such as the microglia, epithelial cells,
skeletal muscle cells, osteocytes and cardiomyocytes (Shi et al.,
2003; Yachi et al., 2007; Liu et al., 2013; Pan et al., 2014).
Functionally, GILZ mimics the anti-inflammatory and the
anti-proliferative effects of GC by inhibiting the activated NF-κB
and by upregulating the transcription of anti-inflammatory genes
such as IL-10 (Berrebi et al., 2003; Mazzon et al., 2014).
GILZ is induced in the brain by both MR and GR
mediated transactivation (Bergann et al., 2011). Since GC
exhibit over 10-fold higher affinity for MR than GR, it is
likely that under physiological conditions of low GC, GILZ
induced by the high affinity MR assists in maintaining the
homeostasis in the CNS. When GC is elevated, impaired
feedback and increased cytoplasmic retention of GC could
result in reduced GILZ induction contributing to dysregulated
cellular responses (Rupprecht et al., 1993; Ogita et al., 2012).
Stress induced GC upregulates the toll like receptors (TLRs)
in microglia primed by immune activation (Frank et al.,
2010). In addition, GILZ induction has been shown to occur
with varying dynamics in different tissues in vivo, suggesting
that the local environment can modulate its expression
with potential effects on cellular responses (Ayyar et al.,
2015).
In this study, we investigated the role of GILZ in
lipopolysaccharide (LPS) induced neuro-inflammation and its
relation to the innate immune response in the brain. LPS induced
inflammation is a widely used model to study the mechanisms
of neuroinflammation preceding neurodegeneration in AD
pathogenesis (Nazem et al., 2015). Our data suggest that the GILZ
is downregulated and inversely related to the increased TLR-4
expression in the brain in LPS induced neuroinflammation.
MATERIALS AND METHODS
Animals and Disease Induction
LPS from Escherichia coli 026:B6, = 10,000 EU/mg, was
purchased from Sigma (Sigma Aldrich, St. Louis, MO, USA).
Groups of adult C57/6J mice (five/group) were administered
intraperitoneally either LPS at 250 mg/kg in 100 µl of sterile
saline followed by corn oil daily for 6 days (Ifuku et al., 2012;
Catorce and Gevorkian, 2016) or only saline (100 µl) injections.
Un-manipulated naïvemice were included as additional controls.
The animal experiments were approved by the Institutional
animal care and use committee of the Indiana University Purdue
University at Indianapolis.
Histology and Immunohistochemistry
The mice were sacrificed on day 7 by intra-cardial perfusion
of 25 ml of 0.9% saline. Blood was collected prior to infusion.
Brain from each mouse was removed, one half was immediately
frozen and the other half fixed in 4% paraformaldehyde for
paraffin embedding. Hematoxylin and eosin stained sections
were assessed for inflammation. Serial 10 µ thick coronal
sections were immunostained for markers of microglial cells
and astrocytes, GILZ and NF-κB p65 (Ray et al., 2009).
Briefly, after deparaffinization, hydration, antigen retrieval and
blocking non-specific binding (Enzo biosciences, Farmingdale,
NY, USA) the sections were incubated overnight with the
anti-Iba-1 (Clone:AIF1) or anti-glial fibrillary acidic protein
(GFAP; clone GA5) or anti-NFκB p65 (clone 12H11; EMD
Millipore Corporation, Temecula, CA, USA) or anti-GILZ
polyclonal antibody (Cat #PA5-34506; Invitrogen, Carlsbad,
CA, USA) primary antibody. Brown staining observed by
using the IHC select peroxidase conjugated streptavidin-biotin
system was considered positive (Millipore). For each marker,
the specificity of staining was confirmed by incubating a
separate set of sections with secondary antibodies alone.
The area of positive staining in the dentate gyrus (DG)
and the Cornu Ammonis (CA1 and CA3) regions of each
stained section was quantified by ImageJ software (NIH Image
1.62).
Enzyme Linked Immunosorbent Assay
The cytokines IL-6, TNF-α, and IL-17 in serum from each blood
sample was quantitated using OptEIA kits (BD Biosciences,
San Jose, CA, USA).
Real Time Polymerase Chain Reaction
Total cellular RNA isolated from each brain tissue using
Qiagen kit (Invitrogen, Carlsbad, CA, USA) was reverse
transcribed using iScript cDNA kit (Biorad, Hercules, CA,
USA). Equal amount of cDNA was used for amplification
of β-actin, IL-1β, IL-12, CD14, TLR-4 and CD4 by
quantitative real time polymerase chain reaction (PCR)
using SYBR green/ROX qPCR master mix (SA Biosciences,
Frederick, MD, USA) on the ABI Prism 7000 sequence
detection system (Applied Biosystem, Foster City, CA, USA;
Srinivasan and Janardhanam, 2011). The primers (gene
accession number) used were: β-actin (NM_007393): F-5′TC
ATGAAGTGTGACGTTGACATCCGTA3′; R-5′CCTAGAAG
CATTTGCGCTGCACGATGG3′ (286bp); IL1β (NM_008361)
F-5′AGCTGATGGCCCTAAACAGA3′; R-5′GGTCGGAGATT
CGTAGCTGG3′ (89bp); CD14 (NM_009841) F-5′GAGCTAG
ACGAGGAAAGTTGT3′; R-5′ACCGTAAGCCGCTTTAAGGA
CAGA3′ (206bp); GILZ (NM_001077364) F-5′CTAGCTCCG
CAGGTGCGCAC3′; R-5′CGAGGCCAACAGGTGAGCGG3′
(122bp), IL-12 (NM_001303244) F-5′GGAAGCACGGCAGCA
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GAATA3′; R-5′AACTTGAGGGAGAAGTAGGAATGG3′
(179bp), TLR4 (NM_021297) F-5′CAGTCGGTCAGCAAACGC
CTTCTTC; R-5′TGTAACTGGTGGCAGCGCA3′ (216bp);
CD4 (NM_013488) F-5′GAGAGTCAGCGGAGTTCTC3′;
R-5′CTCACAGGTCAAAGTATTGTTG3′ (182bp). The gene
specific threshold cycle (Ct) was corrected by subtracting the Ct
for the housekeeping gene β-actin. The magnitude of change
in each gene was determined by the 2−∆Ct method. Each
measurement of a sample was performed in duplicates and the
experiments were repeated at least two times.
Statistical Analysis
Pairwise Student’s t-test was used to determine statistical
significance in the cytokine and mRNA expression between
the naïve, saline and LPS treated groups. p < 0.05 was
considered significant. The relationship between the GILZ and
TLR4 transcripts was evaluated by regression analysis, Pearson
and Spearman correlation coefficient.
RESULTS
LPS Induced Neuroinflammation Exhibits
Increased Gliosis and Reduced GILZ
Protein Expression
Peripherally administered LPS has been shown to increase the
number of activated microglial cells as well as astrogliosis in
the brain (Qin et al., 2007; Catorce and Gevorkian, 2016). We
observed that the mean area of Iba+ microglial (Figures 1B,I)
and GFAP+ astrocytes staining (Figures 1D,I) was higher in
specific regions of the hippocampus of mice subjected to LPS
induced neuroinflammation as compared to that in vehicle
treated mice (Figures 1A,C,I). We also observed that the
p65 immununostaining was higher in the DG and CA1 regions
of the hippocampus of LPS administered mice (Figures 1F,I)
as compared to that of the control mice (Figures 1E,I).
While the control group of mice exhibited increased GILZ
staining (Figures 1G,I), GILZ+ cells were fewer in DG and
CA1 region the hippocampus of mice subjected to LPS induced
neuroinflammation (Figures 1H,I).
The GILZ Transcript Correlates Inversely
With the Innate Immune and Inflammatory
Transcripts in LPS Induced
Neuroinflammation
The inflammatory cytokines TNF-α and IL-17 was significantly
higher in the serum of mice subjected to LPS induced
neuroinflammation as compared to the serum of control group
(Figure 2B). TLR4 is one of the main LPS recognizing receptors
that respond to inflammatory stimuli and mediate NF-κB
signaling pathway in microglial cells (Yu et al., 2015; Lykhmus
et al., 2016). We observed that the expression of the TLR4mRNA
(Figures 2A,G) and that of its co-receptor CD14 (Figures 2A,H)
was upregulated in the brain tissues of mice subjected to LPS
induced neuroinflammation as compared to that in control
mice. The upregulation was also observed for the transcripts
FIGURE 1 | Immunohistochemistry of hippocampus of mouse induced
neuroinflammation. Shows representative IHC section stained for Iba+
microglia (A,B), glial fibrillary acidic protein (GFAP)+ astrocytes (C,D), nuclear
factor-kappa B (NF-κB) p65+ (E,F) and GLIZ+ cells (G,H) in the hippocampus
of mouse subjected to lipopolysaccharide (LPS) induced neuroinflammation
and vehicle treated mouse as indicated. Panel (I) shows the mean staining
area of the 3,3′-diaminobenzidine (DAB)-positive cells depicting microglia,
astrocytes, NF-κB p65 or GILZ+ cells in groups of mice induced
neuroinflammation or vehicle treated mice (DG, dentate gyrus; CA 1, Cornu
Ammonis 1; and CA 3, Cornu Ammonis 3; representing specific regions of the
hippocampus). ∗p < 0.05 as compared with vehicle treated mice.
of inflammatory markers CD4 and IL-1α (Figures 2A,C–E). In
contrast, the GILZ mRNA was significantly lower in the brain
tissues of mice subjected to LPS induced neuroinflammation as
compared to that of the control group (Figures 2A,F). Regression
analysis suggests a strong positive correlation between GILZ
and TLR-4 (Spearman R = 0.9) expression in individual mouse
in the control group (Figure 2I). This relationship was lost in
individual mice subjected to LPS induced neuro-inflammation
(Figure 2J).
DISCUSSION
Brain is well recognized as a major neural target for the
actions of GC. The paradoxical effects of GC in neuronal
survival and death have been attributed to the concentration and
duration of exposure of GC and the bioavailability of receptors.
In physiological conditions and during circadian trough, GC
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FIGURE 2 | Effect of LPS induced neuroinflammation in the expression profiles of inflammatory markers and GILZ: groups of adult C57BL/6 mice were subjected to
LPS induced neuroinflammation as described in the “Materials and Methods” section. Equal quantity of cDNA isolated from brain tissues were amplified for IL-1β,
CD14, toll like receptor-4 (TLR-4), IL-12, CD4 and β-actin mRNA by quantitative real time polymerase chain reaction (PCR). (A) Gel electrophoresis of the PCR
products β-actin IL-1β, CD14, TLR-4, GILZ, IL-12 and CD4. Panel (B) shows indicated inflammatory cytokines in the circulation as determined by enzyme linked
immunosorbent assay (ELISA). (C–H) Relative mRNA quantitation of the indicated product with respect to that of housekeeping gene β-actin is shown. Data are
average ± SD. ∗ and @p < 0.05 with respect to the vehicle treated group or naïve group respectively. Panel (I,J) shows data from regression analysis for GILZ and
TLR4 transcripts in mice administered saline (I) or LPS (J).
preferably bind high-affinity MR and mediate neuroprotective
responses. High GC on the other hand promote neuronal injury
by increasing inflammation and potentiating other cytotoxic
mechanisms (Duque Ede and Munhoz, 2016; Kalafatakis et al.,
2016). We postulated that since GILZ is an early and rapidly
induced gene by GC, it is likely that it influences these
processes.
Intraperitoneal LPS upregulate inflammatory cytokines which
in turn increase glucocorticoid secretion. Yet, considerable
evidence suggest that the LPS induced neuroinflammation is
aggravated by higher circulating GC or chronic stress induced
GC or exogenous GC due to development of glucocorticoid
resistance and impaired feedback (Weidenfeld and Yirmiya,
1996; Pérez-Nievas et al., 2010; Vyas et al., 2016). We
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observed that the GILZ expression was reduced in the
hippocampus in this model correlating negatively with the
increased inflammatory markers. Others have reported reduced
GILZ expression in LPS induced uveitis (Gu et al., 2017).
Previously, reduced GILZ expression and elevated inflammatory
cytokines in circulating lymphocytes were correlated with
lower hippocampal volume in patients with major depressive
disorder (Frodl et al., 2012). In contrast, water immersion
stress that enhance endogenous GC was shown to upregulate
neuronal GILZ in the mouse hippocampus (Yachi et al.,
2007). The discrepancy could be attributed to the nature of
the stimuli and the method used, in situ hybridization vs.
quantitative PCR (this study). Pertinently, GILZ has been
suggested to exert cell-context dependent functions ranging
from inhibition of inflammation and immune responses to
modulation of proliferation and cell death in multiple cell
types (Cohen et al., 2006; Liu et al., 2013; Pan et al.,
2014).
Data from serial gene expression analysis that characterized
the global transcriptional effects of MR and GR signaling in
GR deficient HT-22 neuronal cells showed that the GILZ is
upregulated only in cells co-expressing MR and GR (Rozeboom,
2008). These observations suggest that the GILZ could contribute
to the process of neuronal survival and apoptosis, perhaps in
a GC concentration dependent manner. Our observations of
higher GILZ expression in the brain of naïve mice suggest
that in health GILZ is potentially upregulated by MR mediated
transactivation. The reduced GILZ expression in LPS induced
TLR-4 mediated inflammation perhaps reflects cytoplasmic GR
retention with consequent reduced GILZ transactivation. Similar
inverse correlation between the TLR-4 and GILZ expression is
reported in alveolar macrophages (Hoppstadter et al., 2012).
Taken together, our data suggest a novel role for GILZ
as a modulator of the neuroprotective and neuroinflammatory
responses of GC. Further studies are underway to evaluate the
effects of stress and inflammation in GILZ overexpressing mice.
In addition, since GILZ sequesters activated NF-κB p65 in the
cytoplasm and prevent inflammatory responses, it may represent
a viable candidate for drug development (Ayroldi and Riccardi,
2009). Indeed, we have recently reported that analogs of the
p65 binding motif of GILZ can inhibit amyloid beta induced
inflammatory responses in mixed brain cells (Srinivasan et al.,
2016).
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